As genetic engineering and DNA manipulation tools like CRISPR continue to advance, the distinction between what science ‘could’ and ‘should’ do becomes murkier.
Disiplin ilmiah, gaya jurnalistik
Artikel-artikel mengenai Human Genome Project
Menampilkan 1 - 20 dari 46 artikel
The African BioGenome Project is a pan-African project that seeks to sequence Africa’s endemic and indigenous plants and animals.
Advances in technology have enabled researchers to sequence the large regions of repetitive DNA that eluded the Human Genome Project.
Record-breaking technology can sequence an entire human genome in a matter of hours. The work could be a lifeline for people suffering from the more than 5,000 known rare genetic diseases.
Three pioneering technologies have forever altered how researchers do their work and promise to revolutionize medicine, from correcting genetic disorders to treating degenerative brain diseases.
Two decades after the ‘full’ human genetic code was released to global fanfare, researchers have finally filled in the blanks that made up 8% of the sequence, thanks to recent advances in genome sequencing.
The first full human genome was sequenced 20 years ago. Now, a project is underway to sequence 1 million genomes to better understand the complex relationship between genetics, diversity and disease.
The achievement didn’t live up to the hype, but it has illuminated new areas of ‘genetic dark matter’.
Genome sequencing technologies have transformed biological research in many ways, but have had a much smaller effect on the treatment of common diseases.
Nearly 20 years ago, Bill Clinton said that sequencing the human genome would give us a “new power to heal”.
A new study in Nature finds that large research teams develop recent ideas, while small teams conduct more disruptive and innovative research.
In 2003 the Human Genome Project “cracked the code of life”, yet parts of our DNA remained unidentified. A new study fills out our genetic blueprint by using a nanotechnology-based technique.
Cancer researchers dream of offering personalized treatments to patients. Can they get there using the same math that drives Netflix recommendations?
A recent closed meeting about building synthetic genomes raised suspicions about just what scientists were planning, away from the public eye.
It seems like a no brainer to edit out genetic disease…until we pause to consider what would be lost.
The compact system that can cut the process of sequencing the Ebola virus from weeks to days.
There’s still a lot we don’t know about how various genes are switched on and off. But a new project is seeking to shed light on the complex world of epigenetics.
Hidden among all the other announcements in last week’s State of the Union address by US President Barack Obama was a promise to fund a new “precision medicine initiative”. The president said it would…
Walter Gilbert won the Nobel Prize in 1980 in Chemistry for his contribution to sequence DNA, or “determination of base sequences in a nucleic acid”. Mohit Kumar Jolly, researcher at Rice University and…
“Arthritis is for old people, right?” This is an outdated view of a spectrum of diseases that affect people of all ages in the population. In the past decade, there has been a revolution in the understanding…
Kontributor teratas
-
Chair Precision Medicine, Monash University
-
Honorary Fellow, Department of Pathology, The University of Melbourne
-
Head, Molecular Medicine Laboratory, Walter and Eliza Hall Institute
-
Professor of Genomics, The University of Melbourne
-
Merlin Crossley adalah Sahabat The Conversation.
Deputy Vice-Chancellor Academic Quality and Professor of Molecular Biology, UNSW Sydney
-
Reader, Molecular Genetics, University of Aberdeen
-
Professor; Director, Menzies Research Institute, University of Tasmania
-
Associate Professor, School of Law, University of Canberra
-
Science writer, author, zoologist & Fellow, Academy of Medical Sciences (UK)
-
Emeritus Professor of Law, University of Sydney
-
Professor of Law & Adjunct Professor, Faculty of Medicine Dentistry and Health Sciences, The University of Melbourne
-
Dr; Senior Researcher, Data61
-
Senior Research Engineer, The University of Melbourne
-
Clinical Immunologist, Westmead Millenium Institute, University of Sydney
-
Professor- Clinical & Experimental Pharmacology, University of Adelaide
